Skip to content

Lakefront Biotherapeutics

US · LKFT #2803 by market cap Listed 1970
33.31 -0.08 -0.24%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:26

About Lakefront Biotherapeutics

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Founded
1999
CEO
Mr. Henry O. Gosebruch
Employees
452
Headquarters
Mechelen, Brussels Region, Belgium
Fiscal year end
12-31
Website
lakefrontbio.com

Company profile

Exchange
US
Symbol
LKFT
Market-cap rank
#2803
Listing date
1970-01-01
Market cap
2.18B
Float cap
796.48M
Shares out
65.48M
Float shares
23.91M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 16:26:21 · For reference only, not investment advice and not tailored to your situation.

Lakefront Biotherapeutics discussion 0 comments

Add a comment